Small Businesses |
|
|
Clinical Trial: Non-small Cell Lung Cancer Study US75 (Z-PACT)
This study is currently recruiting patients.
|
Purpose
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Non Small Cell Lung Carcinoma | Drug: zoledronic acid Drug: Taxotere Drug: Carboplatin | Phase III |
MedlinePlus related topics: Cancer; Lung Cancer
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Secondary Outcomes: Time to disease progression; Response rate; Time to progression in bone; Overall survival; Safety
Expected Total Enrollment: 250
Study start: April 2004; Expected completion: June 2007
Data entry closure: July 2007
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Male or Female patients at least of 18 years old
- Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
- Women must not be pregnant or attempting to become pregnant
- Able and willing to sign informed consent
Exclusion Criteria:
- Patients with cancer that has spread to the bone
- Patients with cancer that has spread to the brain who are receiving treatment
- Patients with kidney disease
- Patients treated with other investigational drugs
Location and Contact Information
Alabama
Clinical Research Consultants, Hoover, Alabama, 35216, United States; Recruiting
Luigi Bertoli, MD, Principal Investigator
Clinical Research Consultants, Hoover, Alabama, 35216, United States; Recruiting
James Carinder, MD, Principal Investigator
Arizona
Arizona Oncology Assoc., Tucson, Arizona, 85715, United States; Recruiting
Manual Modiano, MD, Principal Investigator
Arkansas
Highlands Oncology Group, Springdale, Arkansas, 72764, United States; Recruiting
Thaddeus Beck, MD, Principal Investigator
NEA Clinic, Jonesboro, Arkansas, 72401, United States; Recruiting
Allen Nixon, MD, Principal Investigator
California
NorthBay Cancer Center, Fairfield, California, 94533, United States; Recruiting
James M. Long, MD, Principal Investigator
UCLA, Los Angeles, California, 91401, United States; Recruiting
Robert Figlin, MD, Principal Investigator
Colorado
Northern Hematology-Oncology, Thornton, Colorado, 80260, United States; Recruiting
William Eng. Lee, MD, Principal Investigator
Cancer Center of Colorado Springs, Colorado Springs, Colorado, 80907, United States; Recruiting
David Brantley, MD, Principal Investigator
Florida
Oceola Cancer Center, Kissimmee, Florida, 34741, United States; Recruiting
Arnold I. Miller, MD, Principal Investigator
Innovative Medical Research of South Florida, Inc., Miami Shores, Florida, 33138, United States; Recruiting
Marc A. Saltzman, MD, Principal Investigator
New Hope Cancer Centers, Hudson, Florida, 34667, United States; Recruiting
Jorge Ayub, MD, Principal Investigator
VA Medical Center, Miami, Florida, 33125, United States; Recruiting
Lucy Chua, MD, Principal Investigator
Lynn Regional Cancer Center, Boca Raton, Florida, 33428, United States; Recruiting
Elena Kruglyak, MD, Principal Investigator
Hematology-Oncology Associates, Pensacola, Florida, 32501, United States; Recruiting
Allen Patton, MD, Principal Investigator
Metcare Oncology, Ormond Beach, Florida, 32174, United States; Recruiting
Mitchell Weisberg, MD, Principal Investigator
Georgia
Peachtree Hematology & Oncology, Atlanta, Georgia, 30309, United States; Recruiting
Charles Henderson, MD, Principal Investigator
Emory University, Atlanta, Georgia, 30322, United States; Recruiting
Michael Fannuchi, MD, Principal Investigator
Hawaii
Straub Clinic & Hospital, Honolulu, Hawaii, 96813, United States; Recruiting
Galen Choy, MD, Principal Investigator
Kaiser Foundation Hospital, Honolulu, Hawaii, 96819, United States; Recruiting
Charles Miller, MD, Principal Investigator
Illinois
OSF Center for Cancer Care, Rockford, Illinois, 61108, United States; Recruiting
Richard Nora, MD, Principal Investigator
Indiana
Northern Indiana Oncology Associates, South Bend, Indiana, 46617, United States; Recruiting
Rudolph Modesto Navari, MD, Principal Investigator
Oncology Institute of Greater Lafayette, Lafayette, Indiana, 47904, United States; Recruiting
Thomas Jones, MD, Principal Investigator
Community Hospital, Cancer Research Dept., Munster, Indiana, 46321, United States; Recruiting
Erwin Robin, MD, Principal Investigator
Iowa
Cedar Valley Medical Specialists, Waterloo, Iowa, 50702, United States; Recruiting
Joginder Singh, MD, Principal Investigator
Kansas
Kansas City Cancer Ctr. South, Lenexa, Kansas, 66214, United States; Recruiting
Kelly Pendergrass, MD, Principal Investigator
Louisiana
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, 70809, United States; Recruiting
David S Hanson, MD, Principal Investigator
Hematology/Oncology Clinic, Baton Rouge, Louisiana, 70808, United States; Recruiting
Gerald P. Miletello, MD, Principal Investigator
LSU Health Sciences Center, Shreveport, Louisiana, 71103, United States; Recruiting
Glenn M Mills, MD, Principal Investigator
Maine
Maine Center for Cancer Medicine, Scarborough, Maine, 04074, United States; Recruiting
Tracey F. Weisberg, MD, Principal Investigator
Maryland
Oncology Care Associates, Bethesda, Maryland, 20817, United States; Recruiting
Cheryl A. Aylesworth, MD, Principal Investigator
Massachusetts
Berkshire Hematology Oncology PC, Pittsfield, Massachusetts, 01201, United States; Recruiting
Harvey Zimbler, MD, Principal Investigator
Michigan
Karmanos Cancer Institute, Detroit, Michigan, 48201, United States; Recruiting
Antoinette Wozniak, MD, Principal Investigator
Missouri
St. Louis Cancer Care, Chesterfield, Missouri, 63017, United States; Recruiting
Daniel Cuevas, MD, Principal Investigator
Nebraska
Odyssey Research, Scottsbluff, Nebraska, 69361, United States; Recruiting
Vince Bjorling, MD, Principal Investigator
Nevada
Nevada Cancer Center, Las Vegas, Nevada, 89109, United States; Recruiting
Carlos William Araujo, MD, Principal Investigator
Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States; Recruiting
John A. Ellerton, MD, Principal Investigator
New Jersey
Hematology/Oncology Assoc. of South Jersey, Mt. Holly, New Jersey, 08060, United States; Recruiting
Michael Entmacher, MD, Principal Investigator
Cancer Institute of New Jersey at Cooper University Hospital, Voorhees, New Jersey, 08043, United States; Recruiting
Alexandre Hageboutros, MD, Principal Investigator
East Orange VA Medical System, East Orange, New Jersey, 07018, United States; Recruiting
Basil Kasimis, MD, Principal Investigator
Howell Office Plaza, Howell, New Jersey, 07731, United States; Recruiting
Kenneth Nahum, MD, Principal Investigator
New Mexico
New Mexico Cancer Care Associates, Santa Fe, New Mexico, 87505, United States; Recruiting
Timothy M. Lopez, MD, Principal Investigator
New Mexico Oncology Hematology Consultants, Ltd., Albuquerque, New Mexico, 87109, United States; Recruiting
Richard Guidice, MD, Principal Investigator
New York
Syracuse VA Medical Center, Syracuse, New York, 13210, United States; Recruiting
Ajeet Gajra, MD, Principal Investigator
James P. Wilmot Cancer Center, Rochester, New York, 16642, United States; Recruiting
Kishan Pandya, MD, Principal Investigator
North Carolina
Southern Oncology Research, Grifton, North Carolina, 28530, United States; Recruiting
J. Thomas Lee, MD, Principal Investigator
Presbyterian Hospital, Charlotte, North Carolina, 28204, United States; Recruiting
Richard B. Reiling, MD, Principal Investigator
Ohio
Barberton Citizens Hospital-Cancer Center, Barberton, Ohio, 44203, United States; Recruiting
Sandra Hazra, MD, Principal Investigator
Dayton Clinical Oncology Program, Dayton, Ohio, 45429, United States; Not yet recruiting
Nandagopal Vrindavanam, MD, Principal Investigator
Oklahoma
Cancer Specialists of Oklahoma, Oklahoma City, Oklahoma, 73112, United States; Recruiting
Charles Hollen, MD, Principal Investigator
Oregon
Hematology Oncology Associates, Medford, Oregon, 97504, United States; Recruiting
Gerald Ahmann, MD, Principal Investigator
South Carolina
Charleston Hematology Oncology, Charleston, South Carolina, 29403, United States; Recruiting
George F. Geils, Sr., MD, Principal Investigator
Santee Hematology/Oncology, Sumter, South Carolina, 29150, United States; Recruiting
Bill Clowney, MD, Principal Investigator
Charleston Cancer Center, Charleston, South Carolina, 29406, United States; Recruiting
Charles S. Holladay, MD, Principal Investigator
Tennessee
The Jones Clinic, Germantown, Tennessee, 38138, United States; Recruiting
C. Michael Jones, MD, Principal Investigator
Texas
Blood and Cancer Center of East Texas, Tyler, Texas, 75701, United States; Recruiting
Gary E. Gross, MD, Principal Investigator
Cancer Specialists of South Texas, Corpus Christi, Texas, 78412, United States; Recruiting
Albert J. Wood, MD, Principal Investigator
West Virginia
West Virginia University, Morgantown, West Virginia, 26506, United States; Recruiting
John Rogers, MD, Principal Investigator
More Information
Record last reviewed: March 2005
Last Updated: March 21, 2005
Record first received: June 29, 2004
ClinicalTrials.gov Identifier: NCT00086268
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Small Businesses (Centers for Disease Control and Prevention)

Not Signed In -

